Validation of p53 immunohistochemistry as a prognostic factor in breast cancer in clinical practice.

Archives of Pathology & Laboratory Medicine
Angela N Bartley, Dennis W Ross

Abstract

Abnormal p53 tumor suppressor gene expression as detected by immunohistochemistry is a possible prognostic factor in breast cancer. The difference in techniques used to evaluate the expression of mutated p53 protein is under intense scrutiny, as well as its uses either independently or in conjunction with other prognostic factors in breast cancer. To determine whether p53 immunohistochemistry can be used as a reliable indicator of the presence of mutated nuclear p53 protein, and whether this method can be performed reliably in a community hospital's clinical practice. ne hundred twenty-two cases of breast carcinoma were stained and analyzed for the presence of p53 protein using DO-7 (Dako Corporation, Carpinteria, Calif) p53 antibody. Of the 122 cases of invasive carcinoma studied, 23 (18.7%) were positive for p53, and 16 (16.3%) of 98 cases with coexisting ductal carcinoma in situ were positive for p53. This finding is in agreement with comparable published studies. Based on the results of this study, we conclude that p53 immunohistochemistry qualifies as a diagnostic technique suitable for clinical practice in a community hospital. Its detection may be particularly promising in clinical trials of new molecular therapies direc...Continue Reading

References

Feb 1, 1995·Human Pathology·C CharpinL Piana
Nov 1, 1993·Pathology, Research and Practice·J Hurlimann
Jun 16, 1993·Journal of the National Cancer Institute·R SilvestriniU Veronesi
Nov 1, 1995·The Journal of Pathology·T PietiläinenK Syrjänen
Feb 6, 1996·Proceedings of the National Academy of Sciences of the United States of America·J S KovachS S Sommer
May 1, 1996·The Journal of Pathology·L L NakopoulouA Keramopoulos
Mar 17, 2000·International Journal of Cancer. Journal International Du Cancer·H BlaszykS S Sommer
Jun 10, 2000·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J M FerreroG Milano
Jul 11, 2000·Archives of Pathology & Laboratory Medicine·P L FitzgibbonsS J Schnitt

❮ Previous
Next ❯

Citations

Dec 23, 2008·Breast Cancer Research : BCR·Alexandra M PietersenMaarten van Lohuizen
Mar 9, 2021·Frontiers in Veterinary Science·Guillermo ValdiviaLaura Peña
Sep 10, 2005·International Journal of Cancer. Journal International Du Cancer·Jian-Yu WuIrmgard Irminger-Finger
Dec 3, 2008·Pathology Oncology Research : POR·Mustafa AkkiprikAyse Ozer
Jul 28, 2009·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·S K SandhuT V Nguyen
Nov 24, 2011·European Journal of Human Genetics : EJHG·Laura ThomasMeena Upadhyaya

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Ductal

Ductal carcinoma is a malignant neoplasm involving the ductal systems of any of a number of organs, such as the mammary glands, pancreas, prostate or lacrimal gland. Discover the latest research on ductal carcinoma here.

Related Papers

Nursing Times
D Robinson-Walsh
Nursing Times
I McMillan
Journal of the National Cancer Institute
K Smigel
Medicina clínica
Andreu Segura
American Journal of Epidemiology
Robert H Fletcher
© 2022 Meta ULC. All rights reserved